1. Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
   William Guiler et al, 2021, Front. Cell. Neurosci. CrossRef
2. Mechanosensing and the Hippo Pathway in Microglia: A Potential Link to Alzheimer’s Disease Pathogenesis?
   Lucrezia Bruno et al, 2021, Cells CrossRef
3. RhoA Signaling in Neurodegenerative Diseases
   Sissel Ida Schmidt et al, 2022, Cells CrossRef
4. ROCK and PDE-5 Inhibitors for the Treatment of Dementia: Literature Review and Meta-Analysis
   Dong-Hun Lee et al, 2022, Biomedicines CrossRef
5. Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?
   Kinga Czarnota-Łydka et al, 2022, IJMS CrossRef
6. Combined targeting of pathways regulating synaptic formation and autophagy attenuates Alzheimer’s disease pathology in mice
   Christiana Bjorkli et al, 2022, Front. Pharmacol. CrossRef
7. What Is the Role of the Rho-ROCK Pathway in Neurologic Disorders?
   Eduardo Benarroch, 2023, Neurology CrossRef
8. Oligomeric Amyloid-β and Tau Alter Cell Adhesion Properties and Induce Inflammatory Responses in Cerebral Endothelial Cells Through the RhoA/ROCK Pathway
   Faruk Hossen et al, 2024, Mol Neurobiol CrossRef
9. New insights on the regulators and inhibitors of RhoA-ROCK signalling in Parkinson’s disease
   Nandita Ravichandran et al, 2025, Metab Brain Dis CrossRef